REGENXBIO Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
44.30
|
|
Average Rating
|
4.20
|
|
# Strong Buys
|
5
|
|
# Buys
|
2
|
|
# Holds
|
3
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-1.46
|
-1.75
|
-0.29
|
-19.86%
|
|
2022-06-30
|
-1.53
|
-1.58
|
-0.05
|
-3.27%
|
|
2022-03-31
|
-1.32
|
-1.79
|
-0.47
|
-35.61%
|
|
2021-12-31
|
4.71
|
6.67
|
1.96
|
41.61%
|
|
2021-09-30
|
-1.08
|
-1.37
|
-0.29
|
-26.85%
|
|
2021-06-30
|
-1.12
|
-1.36
|
-0.24
|
-21.43%
|
|
2021-03-31
|
-1.28
|
-1.20
|
0.08
|
6.25%
|
|
2020-12-31
|
-0.43
|
-1.24
|
-0.81
|
-188.37%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-5.12
|
|
2021-12-31
|
2.74
|
|
2020-12-31
|
-3.00
|
|
2019-12-31
|
-2.59
|
|
2018-12-31
|
2.89
|
|
2017-12-31
|
-2.47
|
|
2016-12-31
|
-2.39
|
|
2015-12-31
|
-1.72
|